Trevena Inc (TRVN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Maxine Gowen
Employees:
29
955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK, PA 19087
6103548840

Trevena, Inc. is a clinical stage biopharmaceutical company. It discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors. The company product pipeline consists of TRV027, TRV130, TRV734, and Delta Opiod. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in King of Prussia, PA.

Data derived from most recent annual or quarterly report
Market Cap 180.96 Million Shares Outstanding164.509 Million Avg 30-day Volume 949.093 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 3.1 / 1.08 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from TRVN instead.

View recent insider trading info

Funds Holding TRVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TRVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHIN BARRY CHIEF FINANCIAL OFFICER

  • Officer
604,715 2021-09-14 4

BOURDOW CARRIE L. PRESIDENT & CEO

  • Officer
  • Director
1,301,510 2021-06-28 4

DOUGHERTY MICHAEL R

  • Director
68,577 2021-05-28 1

MOULDER LEON O JR

  • Director
68,577 2021-05-28 1

NUNN JASON RALEIGH

  • Director
68,577 2021-05-28 1

YANNI BARBARA

  • Director
68,577 2021-05-28 1

PHILLIPS ANNE M.

  • Director
68,577 2021-05-28 1

BRAUNSTEIN SCOTT

  • Director
68,577 2021-05-28 1

JOHNSON MARVIN

  • Director
0 2021-03-18 2

APPLEBAUM SCOTT CLCO; SVP, REGULATORY AFFAIRS

  • Officer
344,022 2021-02-10 2

DEMITRACK MARK SR. VP & CHIEF MEDICAL OFFICER

  • Officer
444,181 2020-12-17 2

YODER ROBERT T SVP, CHIEF COMMERCIAL OFFICER

  • Officer
357,866 2020-12-17 2

GOWEN MAXINE

  • Director
0 2020-05-13 0

MCHUGH JULIE

  • Director
0 2020-05-13 0

HAMILL JOHN P. VP FIN,PRINC FIN&ACCT OFFICER

  • Officer
82,234 2019-05-31 0

KOPPEL ADAM

  • Director
0 2018-05-16 0

HABIB YACOUB SVP, BUS DEV & CORP PLANNING

  • Officer
0 2018-03-22 0

LIMONGELLI JOHN M SR. VP,GENERAL COUNSEL & CAO

  • Officer
0 2018-02-28 0

CUCA ROBERTO SR. VP AND CFO

  • Officer
0 2018-02-28 0

GEOGHEGAN DAVID SR. VP, OPERATIONS

  • Officer
0 2018-02-28 0

VIOLIN JONATHAN SVP-SCIENTIFIC AFFAIRS & IR

  • Officer
0 2018-02-28 0

LARK MICHAEL W. SR. VP, RESEARCH & CSO

  • Officer
0 2017-08-28 0

SOERGEL DAVID SR. VP,CLINICAL DEV. & CMO

  • Officer
0 2017-03-02 0

NADER FRANCOIS

  • Director
0 2015-05-20 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRETT M JAMES

BARRIS PETER J

BASKETT FOREST

DRANT RYAN D

KERINS PATRICK J

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
4,811,691 2014-12-10 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

CHAMPSI FARAH

JANNEY DANIEL

NOHRA GUY P

  • Director
  • 10% Owner
4,390,262 2014-12-10 0

DEEGAN ROSAMOND SR VP, BUS DEV & OPERATIONS

  • Officer
31,105 2014-09-29 0

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

MCGUIRE TERRANCE

FLINT JONATHAN A

  • 10% Owner
3,769,280 2014-08-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SHIN BARRY - Officer CHIEF FINANCIAL OFFICER

2021-09-16 18:10:39 -0400 2021-09-14 A 27,500 a 563,465 direct -8.0882 -9.5588 0.0 1 -10.2941 3

SHIN BARRY - Officer CHIEF FINANCIAL OFFICER

2021-09-16 18:10:39 -0400 2021-09-14 A 41,250 a 41,250 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TREVENA INC TRVN 2021-10-26 19:15:03 UTC -2.0869 2.1569 4500000
TREVENA INC TRVN 2021-10-26 18:45:03 UTC -2.0869 2.1569 4500000
TREVENA INC TRVN 2021-10-26 18:15:03 UTC -2.0869 2.1569 4500000
TREVENA INC TRVN 2021-10-26 17:45:03 UTC -2.0869 2.1569 4500000
TREVENA INC TRVN 2021-10-26 17:15:03 UTC -2.0869 2.1569 4500000
TREVENA INC TRVN 2021-10-26 16:45:04 UTC -2.1387 2.2087 4500000
TREVENA INC TRVN 2021-10-26 16:15:03 UTC -2.1387 2.2087 4500000
TREVENA INC TRVN 2021-10-26 15:45:03 UTC -2.1387 2.2087 4500000
TREVENA INC TRVN 2021-10-26 15:15:03 UTC -2.1387 2.2087 4400000
TREVENA INC TRVN 2021-10-26 14:45:03 UTC -2.1414 2.2114 4300000
TREVENA INC TRVN 2021-10-26 14:15:05 UTC -2.1414 2.2114 4300000
TREVENA INC TRVN 2021-10-26 13:45:03 UTC -2.1414 2.2114 4300000
TREVENA INC TRVN 2021-10-26 13:15:03 UTC -2.1414 2.2114 4300000
TREVENA INC TRVN 2021-10-26 12:45:03 UTC -2.1414 2.2114 4300000
TREVENA INC TRVN 2021-10-25 22:15:03 UTC -2.1414 2.2114 4500000
TREVENA INC TRVN 2021-10-25 21:45:03 UTC -2.1576 2.2276 4500000
TREVENA INC TRVN 2021-10-25 21:15:03 UTC -2.1576 2.2276 4500000
TREVENA INC TRVN 2021-10-25 20:45:03 UTC -2.1576 2.2276 4500000
TREVENA INC TRVN 2021-10-25 20:15:03 UTC -2.1576 2.2276 4500000
TREVENA INC TRVN 2021-10-25 19:45:04 UTC -2.1576 2.2276 4500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments